Catalyst Wire Dossier Catalyst Wire Dossier

Trevaclyn

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Trevaclyn, covering 2012-12-21 to 2013-05-16. Get the full timeline:

Most recent: EMA Withdrawn: Trevaclyn (laropiprant;nicotinic acid) — Merck Sharp Dohme Ltd

See pricing